GNBT Stock Price, News & Analysis

GNBT OTC

Company Description

GNBT (OTC: GNBT) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

GNBT stock has declined 99.0% over the past year.

This page provides a comprehensive overview of GNBT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-99.03%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

GNBT (GNBT) stock. Over the past 12 months, the stock has lost 99.0%.

Latest News

View All

July 26, 2021

-99.57%

Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA

fda approval

June 22, 2021

-99.57%

NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm

May 11, 2021

-99.57%

Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services

May 10, 2021

-99.57%

Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets

conferences covid-19

May 6, 2021

-99.57%

Generex Biotechnology Subsidiary NuGenHealth Contracts with Florida Health Care Associates to Provide Remote Patient Monitoring (RPM) Services

May 5, 2021

-99.57%

Generex Provides Clarification on Its Ii-Key COVID-19 Complete Vaccine China Partnership Agreement

partnership covid-19

GNBT has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 10 with negative movement. Key topics include fda approval, conferences, covid-19, partnership. View all GNBT news →

SEC Filings

View All

No SEC filings available for GNBT.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

GNBT Company Profile & Sector Positioning

GNBT (GNBT) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.